Updated clinical data from the melanoma expansion cohort of an ongoing ph1/1b study of eganelisib (formerly IPI-549) in combination with nivolumab Meeting Abstract


Authors: Postow, M.; Sullivan, R.; Cohen, E.; Gutierrez, M.; Hong, D.; Steuer, C.; McCarter, J.; Zizlsperger, N.; Kutok, J.; O'Connell, B.; Roberts, J.; Page, K.; Zhang, H.; Chmielowski, B.
Abstract Title: Updated clinical data from the melanoma expansion cohort of an ongoing ph1/1b study of eganelisib (formerly IPI-549) in combination with nivolumab
Meeting Title: 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 8
Issue: Suppl. 3
Meeting Dates: 2020 Nov 9-14
Meeting Location: Virtual
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2020-11-01
Start Page: A264
End Page: A265
Language: English
ACCESSION: WOS:000616665300422
DOI: 10.1136/jitc-2020-SITC2020.0434
PROVIDER: wos
Notes: Meeting Abstract: 434 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    361 Postow